Literature DB >> 19450641

Skin-specific promoters for genetic immunisation by DNA electroporation.

Gaëlle Vandermeulen1, Hervé Richiardi, Virginie Escriou, Jing Ni, Philippe Fournier, Volker Schirrmacher, Daniel Scherman, Véronique Préat.   

Abstract

This study aimed at restricting expression of DNA vaccine to specific cell types by using skin-specific promoters (i) to contribute to the understanding of the mechanism of intradermal DNA vaccines and (ii) to address safety concerns associated with DNA vaccines. The expression and immune response after delivery of plasmids encoding luciferase by intradermal DNA electroporation were assessed. Two ubiquitous promoters, CMV and CAG, and three tissue-specific promoters were studied. Keratin 14 promoter restricts gene expression to keratinocytes of the epidermal basal layer, CD11c promoter to dendritic cells and fascin promoter only to mature dendritic cells. The use of plasmids with tissue-specific promoter resulted in significant, but very low protein expression, as compared to that obtained with ubiquitous promoter plasmids. Immunisation with both ubiquitous promoter plasmids elicited humoral and cellular anti-luciferase immune response. No immune response was observed after delivery of CD11c plasmid while fascin and keratin 14 plasmids induced IFN-gamma response suggesting that the targeting of skin-specific cells could be a suitable approach but only for the treatment of pathologies or pathogens requiring mainly cellular and not humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450641     DOI: 10.1016/j.vaccine.2009.05.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Use of Staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene.

Authors:  Anca Reschner; Sophie Scohy; Gaëlle Vandermeulen; Marc Daukandt; Céline Jacques; Benjamin Michel; Hans Nauwynck; Florence Xhonneux; Véronique Préat; Alain Vanderplasschen; Cédric Szpirer
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

2.  Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.

Authors:  Spela Kos; Natasa Tesic; Urska Kamensek; Tanja Blagus; Maja Cemazar; Simona Kranjc; Jaka Lavrencak; Gregor Sersa
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

Review 3.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 4.  What you always needed to know about electroporation based DNA vaccines.

Authors:  Anita Gothelf; Julie Gehl
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

5.  Electroporation-mediated gene delivery.

Authors:  Jennifer L Young; David A Dean
Journal:  Adv Genet       Date:  2014-12-11       Impact factor: 1.944

6.  Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.

Authors:  Viswa Teja Colluru; Christopher D Zahm; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

7.  Electro-gene transfer to skin using a noninvasive multielectrode array.

Authors:  Siqi Guo; Amy Donate; Gaurav Basu; Cathryn Lundberg; Loree Heller; Richard Heller
Journal:  J Control Release       Date:  2011-01-22       Impact factor: 9.776

8.  Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.

Authors:  John R Zibert; Katrin Wallbrecht; Margarete Schön; Lluis M Mir; Grete K Jacobsen; Veronique Trochon-Joseph; Céline Bouquet; Louise S Villadsen; Ruggero Cadossi; Lone Skov; Michael P Schön
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

9.  Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array.

Authors:  B Ferraro; L C Heller; Y L Cruz; S Guo; A Donate; R Heller
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

10.  Development of transgenic minipigs with expression of antimorphic human cryptochrome 1.

Authors:  Huan Liu; Yong Li; Qiang Wei; Chunxin Liu; Lars Bolund; Gábor Vajta; Hongwei Dou; Wenxian Yang; Ying Xu; Jing Luan; Jun Wang; Huanming Yang; Nicklas Heine Staunstrup; Yutao Du
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.